ESFS yields 400000.00% · ABBV yields 3.06%● Live data
📍 ESFS pulled ahead of the other in Year 1
Combined, ESFS + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESFS + ABBV for your $10,000?
Eco Safe Systems USA, Inc. manufactures water treatment and water reclamation systems. It offers R-1000-HS Home Units for food and surface disinfection, and general cleanup in homes; R-1000 Restaurant Single Sink System for food and surface disinfection, and general cleanup in restaurants; R-1000-3S Restaurant Systems for restaurants or supermarkets; and MD-1500 System and MD-1500-C System to handle various departments of supermarkets or restaurants. The company also offers MD-2000 System for use on produce, meat, poultry, and seafood products to reduce bacteria counts, extend the shelf life, and reduce the risk of salmonella or any other bacteria or virus; and Ozone Hazmat Disinfection Systems for emergency first-responders to disinfect and decontaminate personnel and equipment after exposure to various biohazards and pathogens. In addition, it provides leasing services. The company serves various industries, including supermarkets, health care, food processing, restaurants, golf courses, laundry, animal care, and home system. Eco Safe Systems USA, Inc. was incorporated in 1998 and is headquartered in Tarzana, California.
Full ESFS Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.